Noah Beerman COO at Coronado
This article was originally published in Scrip
Coronado Biosciences has appointed Noah Beerman executive vice-president and chief operating officer. Mr Beerman has over 25 years' experience in the biopharmaceutical industry and joined Coronado as a consultant in May 2011. Prior to this, he was president and CEO at Galena Biopharma (previously RXi Pharmaceuticals).
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.